Switzerland features in MLL Legal’s latest counsel promotion round, with the appointment of Zurich-based Thaís Obrist-Bdine (pictured left) and Tomás Navarro Blakemore (pictured right), who works between Geneva and Madrid . Effective from
Schellenberg Wittmer expands its partnership lineup with the appointment of Roland M. Ryser (pictured) in its dispute resolution and white-collar crime practice groups, effective from January 1st 2026. The profile Roland M. Ryser advises and represents
Bratschi has advised the owners of Dokspot — a specialist in electronic Instructions for Use solutions for IVD and medical device manufacturers — on the company’s sale to Matrix One, a portfolio company of Lauxera Capital
Homburger advised Aris Mining Corporation on its acquisition of the remaining 49% interest in the Soto Norte joint venture in Colombia from MDC Industry Holding Company (Mubadala). Pursuant to the deal, Aris Mining Corporation owns 100% of
In its latest promotion round, effective 1 January 2026, Chabrier promoted Thierry Burnens (pictured left) to partner and Stanley Connor (pictured right) to counsel. Thierry Burnens A founding member of Chabrier’s Zurich office, Thierry Burnens leads
Advestra advised Galderma throughout its issuance of CHF 175 million bonds due 2030 with a coupon of 0.9425%. In connection with the transaction, Walder Wyss represented the banking syndicate, including joint lead managers BNP Paribas and UBS. The
Wenger Plattner advised Geneva-based private equity firm Capital Transmission on its investment in DentaCore Group, a vertically integrated dental platform. The Wenger Plattner team Partner Oliver Künzler (pictured) led the Wenger Plattner team on
Bär & Karrer expands its partnership lineup with the appointment of Abdul Carrupt (pictured right), Predrag Sunaric (pictured left), and Stephanie Walter (pictured centre), effective January 1st 2026. Predrag Sunaric Predrag Sunaric specialises in
Advestra advised Bank of America and UBS in connection with their role as joint bookrunners on DocMorris’ placement of CHF 49.6 million convertible bonds due 2028, as well as its public repurchase offer for CHF 87.6 million outstanding
US-based private equity investor SK Capital has aquired Swixx BioPharma Group, a globally active partner in the distribution of biopharmaceutical products with a particular focus to Central and Eastern Europe and Latin America. In connection
